Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon
暂无分享,去创建一个
G. Anderson | P. Dorny | S. Geerts | C. Gauci | M. Lightowlers | A. Zoli | E. Assana | R. De Deken | C. Kyngdon
[1] P. Dorny,et al. Pig-farming systems and porcine cysticercosis in the north of Cameroon , 2010, Journal of Helminthology.
[2] I. Phiri,et al. Taenia solium porcine cysticercosis: viability of cysticerci and persistency of antibodies and cysticercal antigens after treatment with oxfendazole. , 2008, Veterinary parasitology.
[3] G. Fragoso,et al. Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. , 2008, Vaccine.
[4] Shaohua Zhang,et al. Effective Production and Purification of the Glycosylated TSOL18 Antigen, Which Is Protective against Pig Cysticercosis , 2007, Infection and Immunity.
[5] R. Gilman,et al. Strategies for the elimination of taeniasis/cysticercosis , 2007, Journal of the Neurological Sciences.
[6] M. Lightowlers. Cestode vaccines: origins, current status and future prospects , 2006, Parasitology.
[7] G. Fragoso,et al. Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico , 2006, Parasitology.
[8] R. Gilman,et al. Taenia solium and Taenia ovis: stage-specific expression of the vaccine antigen genes, TSOL18, TSOL16, and homologues, in oncospheres. , 2006, Experimental parasitology.
[9] A. Flisser,et al. Antibody responses and epitope specificities to the Taenia solium cysticercosis vaccines TSOL18 and TSOL45‐1A , 2006, Parasite immunology.
[10] H. H. García,et al. Neurocysticercosis: updated concepts about an old disease , 2005, The Lancet Neurology.
[11] R. Gilman,et al. Vaccination of pigs to control human neurocysticercosis. , 2005, The American journal of tropical medicine and hygiene.
[12] A. Flisser,et al. Induction of Protection against Porcine Cysticercosis by Vaccination with Recombinant Oncosphere Antigens , 2004, Infection and Immunity.
[13] C. Evans,et al. Taenia solium cysticercosis , 2003, The Lancet.
[14] J. Brandt,et al. Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa. , 2003, Acta tropica.
[15] Mathurin M'Biandoun,et al. Characterization of climate in four villages in the soudano-sahelian area of North Cameroon and consequences for agriculture. , 2003 .
[16] G. Fragoso,et al. Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. , 2001, Vaccine.
[17] M. Lightowlers. Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. , 1999, International journal for parasitology.
[18] R. Gilman,et al. Treatment of porcine cysticercosis with oxfendazole: a dose-response trial , 1997, Veterinary Record.
[19] R. Gilman,et al. Effective, single-dose treatment or porcine cysticercosis with oxfendazole. , 1996, The American journal of tropical medicine and hygiene.
[20] M. Cruz,et al. Potential eradicability of taeniasis and cysticercosis. , 1993, Bulletin of the Pan American Health Organization.
[21] A. Flisser,et al. Neurocysticercosis in an Orthodox Jewish community in New York City. , 1992, The New England journal of medicine.